ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bristol-Myers Squibb drops phase 3 trials of $800M IDO drug
May 02, 2018David Thompson has left Azure Biotech, the company he helped launch, to join Inozyme Pharma in a newly created position as senior vice president and chief scientific officer. -
Sanofi, Novo back rare disease startup Inozyme in $49M round
November 16, 2017The mission is to help babies with very rare disorders caused by mineral imbalances that can lead to overcalcification of soft tissues and undermineralization of bone, and can all too often cause death.
Pharma Sources Insight January 2025
